WELL Stock Price, News, Filings & Events — Well Health Technologies Corp.

Well Health Technologies Corp. (WELL.TSX) is a digital healthcare company that focuses on improving health outcomes by leveraging technology to empower healthcare practitioners and their patients. The company operates a range of healthcare services, including telehealth platforms, patient management systems, and a database of consented patients for clinical trials and research studies. Their services are designed to enhance the efficiency and accessibility of healthcare delivery. WELL generates revenue primarily through its Canadian Patient Services, which includes telehealth consultations and other healthcare services. Patients, healthcare providers, and life sciences companies are key payers, as patients pay for services, providers utilize WELL's technology for better patient management, and life sciences companies engage with WELL's patient database for research purposes. This multi-faceted approach allows WELL to tap into various revenue streams while addressing the growing demand for digital healthcare solutions.

The most recent material news for WELL Health Technologies Corp. (WELL.TSX) includes the following top three items from the last 90 days: 1. CFO Transition Announcement (September 9, 2026) - Summary : WELL Health announced the appointment of Evelyn Sutherland as the new Chief Financial Officer, effective September 21, 2026. She brings over 20 years of financial leadership experience and has served on the Board of WELL's subsidiary, WELLSTAR. - Importance : This transition is significant as it indicates a strategic shift in financial leadership, which could impact the company's financial management and growth strategy. The experience of Ms. Sutherland may enhance investor confidence in the company's financial direction. 2. WELLTRUST™ Surpasses 100,000 Patient Consents (September 8, 2026) - Summary : WELLTRUST™, a database of consented patients managed by WELL, has surpassed 100,000 patient consents since its launch in February 2026. This database connects patients with clinical trials and research studies. - Importance : This milestone highlights the growing engagement of patients with WELL's services and the potential for increased revenue through clinical trials and partnerships with life sciences companies. It reflects the company's ability to leverage technology for growth in the healthcare sector. 3. Record Quarterly Revenue Milestone (August 6, 2026) - Summary : WELL achieved record quarterly revenues of $400.4 million in Q2-2026, marking a 12% increase compared to Q2-2025, driven by a 32% growth in Canadian Patient Services. - Importance : This strong financial per...

- Strong Revenue Growth : WELL Health achieved record quarterly revenues of $400.4 million in Q2-2026, representing a 12% increase compared to Q2-2025, driven by a 32% growth in Canadian Patient Services revenue to $151.6 million. - Successful Patient Engagement : The WELLTRUST™ database surpassed 100,000 patient consents, enhancing the company's ability to connect patients with clinical trials and research studies, which could lead to increased revenue opportunities. - Strategic Financial Moves : The company redeemed $70 million of its 5.50% convertible debentures, strengthening its balance sheet and reducing debt obligations, which can improve financial flexibility for future growth initiatives. - CFO Transition with Experienced Leadership : The appointment of Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026, brings over 20 years of financial leadership experience, which could enhance strategic financial management and operational efficiency. - Upcoming TSXV Listing for WELLSTAR : The planned TSXV listing and concurrent financing for WELLSTAR, expected to raise approximately $50 million, could unlock value for shareholders and provide capital for further growth in the healthcare technology sector.

- Regulatory Risks : As a digital healthcare company, WELL Health Technologies Corp. is subject to stringent regulations in the healthcare sector. Any changes in healthcare policies or regulations could adversely affect their operations and profitability. - Dependence on Key Personnel : The recent transition of CFO Evelyn Sutherland into the role may create uncertainty. The effectiveness of this transition and the impact on financial strategy and execution are critical to monitor. - Market Competition : The digital healthcare space is highly competitive, with numerous players emerging. WELL must continuously innovate and differentiate its services to maintain market share and growth. - Financial Performance Volatility : Despite achieving record revenues, the company reported a decrease in Adjusted EBITDA in Q2-2026. Continued fluctuations in financial performance could raise concerns among investors regarding sustainability. - Execution Risks in Growth Strategy : WELL's aggressive growth strategy, including the expansion of its subsidiary WELLSTAR, may face execution challenges. Delays or failures in achieving projected milestones could negatively impact investor confidence. - Economic Conditions : Broader economic downturns or changes in consumer spending on healthcare could affect WELL's revenue streams, particularly in their patient services segment, which has shown significant growth.

Upcoming catalysts for Well Health Technologies Corp. (WELL.TSX) in the next 6-12 months include: 1. Earnings Reports : - Q3 2026 Earnings Call : Scheduled for November 2026. This will provide insights into the company's financial performance and strategic direction. 2. CFO Transition : - Transition of CFO : Evelyn Sutherland will officially take over as Chief Financial Officer on September 21, 2026. This change may influence strategic financial decisions and investor confidence. 3. WELLSTAR TSXV Listing : - Proposed TSXV Listing for WELLSTAR : The subsidiary is expected to become publicly listed, which could enhance its valuation and provide a dedicated acquisition currency for growth. 4. Growth in WELLTRUST™ : - Continued expansion of the WELLTRUST™ database, which recently surpassed 100,000 patient consents. This growth could lead to increased partnerships and revenue opportunities in clinical trials and research studies. These events could significantly impact the company's stock performance and investor sentiment.

The most recent earnings call for Well Health Technologies Corp. (WELL.TSX) took place on August 6, 2026. Emphasized Points: - Record Revenue : Management highlighted achieving a record quarterly revenue milestone of $400.4 million in Q2-2026, driven by a 32% revenue growth in Canadian Patient Services. - CFO Transition : The planned transition of the CFO role was discussed, with Evelyn Sutherland appointed as the new Chief Financial Officer, effective September 21, 2026. - Growth Strategy : The focus on leveraging technology to empower healthcare practitioners and patients was reiterated, emphasizing the company's commitment to improving health outcomes. Avoided Points: - Specific details regarding future acquisitions or partnerships were not extensively covered, indicating a cautious approach to discussing potential growth avenues. - There was limited discussion on challenges faced in the market or operational hurdles, suggesting a focus on positive developments. Overall Tone: The overall tone of the call was optimistic and confident, reflecting strong financial performance and strategic leadership changes. Management appeared focused on growth and innovation, reinforcing their commitment to enhancing healthcare technology solutions.